Subscribe to TheStreet's free daily newsletter Once society opened back up, retailers were almost immediately hit with supply ...

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported first-quarter sales—especially those of its key Eylea eye disease drug ...

Zebra stock jumps over 6% after Q1 earnings and sales beat estimates, driven by strong segment growth. CEO sees continued demand into Q2, but trims full-year earnings outlook due to tariff-related ...

reported a solid start to the fiscal year with notable increases in sales and production efficiency. Despite these positive financial and operational metrics, the company’s stock saw a decline ...

Industrial processing equipment and solutions provider Hillenbrand (NYSE:HI) reported Q1 CY2025 results beating Wall Street’s revenue expectations , but sales fell by 8.8% year on year to $715.9 ...

“Consolidated sales were within our guidance range, led by Paint Stores Group.” Sales from stores open more than a year in the Paint Stores Group rose 1.2%, with protective and marine coatings ...

Related: Major drugstore chain closing hundreds of struggling stores Maybe you were in search of a new set of sneakers or ...

The National Retail Federation said it expects U.S. retail sales growth will likely slow slightly in 2025, under pressure from the potential of rising unemployment, falling income and tariff ...

The regulatory clearance allows Morepen to proceed with studies for three dosage strengths - 60mg, 80mg, and 100mg tablets. Clinical trials will follow according to approved protocols, positioning ...